In this context, breast cancer progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) was accompanied by a gradual increase in immune infiltration, particularly involving CD8+ T cells and CD68+ macrophages. Here, CD68 is linked to breast cancer.